Respiratory failure in the acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic
is hypothesized to be driven by an overreacting innate immune response, where the …

Background: New treatment modalities are urgently needed for patients with COVID-19. The
World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or …

Respiratory failure is common and the most severe complication in Coronavirus SARS-CoV-2
disease of 2019 (COVID-19)[1]. We read with much interest the recent article in Your …

It remains unclear which kinds of nanoproducts are available on the European market, although
this information is a prerequisite for any kind of exposure and risk assessment. In order …

… viruses; and urine antigen assays for detection of pneumococcal and L. pneumophila antigens.
… pneumophila was positive; or real-time PCR detection of L. pneumophila or P. jirovecii in …

Background & Aims On-going risk behaviour can lead to hepatitis C virus (HCV) reinfection
following successful treatment. We aimed to assess the incidence of persistent HCV …

To determine how soil properties influence nanoparticle (NP) fate, bioavailability and toxicity,
this study compared the toxicity of nano zinc oxide (ZnO NPs), non-nano ZnO and ionic …

… −1 , men: <50 y 85–249 ng L −1 ; 50–69 y 250–499 ng L −1 ; ≥70 y ≥ 500 ng L −1 ) and/or
cardiac troponins reflecting myocardial damage: troponin T (TnT) (≥14 ng mL −1 ), or TnI (…

In SARS-CoV-2 infection there is an urgent need to identify patients that will progress to
severe COVID-19 and may benefit from targeted treatment. In this study we analyzed plasma …

Objectives To determine the incidence and characteristics of superinfections in mechanically
ventilated COVID-19 patients, and the impact of dexamethasone as standard therapy. …